| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| AL_RIC - Bandi da altri enti di ricerca |
Validazione di due nuovi trattamenti per la sindrome di Rett: focus sui difetti respiratori della malattia
|
|
Ongoing | 2022 |
| INTLI - Finanziamenti internazionali |
Targeting Drp1 activation and mitochondrial Fission tO Curtail muscle wasting during Duchenne MUscular DyStrophy progression (FOCUS)
|
|
Ongoing | 2022 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Targeting allo-reactive Natural Killer cell immune reconstitution in hematologic tumors after bone marrow transplant (3° anno)
|
|
Closed | 2021 |
| FON_NAZ - Bandi Altre Fondazioni |
NK-DC crosstalk in glioma microenvironment explored by single-cell RNAseq (1º anno)
|
|
Closed | 2021 |
| FON_NAZ - Bandi Altre Fondazioni |
Functional relevance of different tetraspanin-like MS4A members for FcRs antitumor activities in target therapies (1º anno)
|
|
Closed | 2021 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Identification of molecular immune-metabolic profiles in pancreatic cancer to advance management of pancreatic diseases (1° anno)
|
|
Closed | 2021 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
All-optical fingerprinting of metastatic potential (3° anno)
|
|
Closed | 2021 |
| FON_NAZ - Bandi Altre Fondazioni |
Evidence-based approach to treat hyperexcitability in Rett syndrome though splicing modulation
|
|
Ongoing | 2021 |
| INTLI - Finanziamenti internazionali |
GM1-oligosaccharide as a new drug candidate for Rett syndrome
|
|
Ongoing | 2021 |
| MIS - Bandi Ministero Salute |
The role of oxidative stress and mitochondrial TERT in the progression and therapeutic resistance of papillary thyroid cancer (TEMPEST)
|
|
Ongoing | 2021 |
